Recap: Autolus Therapeutics Q4 Earnings

Autolus Therapeutics AUTL reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Autolus Therapeutics reported in-line EPS of $-0.51 versus an estimate of $-0.51.

Revenue was down $224.00 thousand from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 5.04% drop in the share price the next day.

Here's a look at Autolus Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.51	-0.50	-0.60
EPS Actual	-0.47	-0.47	-0.53	-0.83
Revenue Estimate	250.00K	190.00K	340.00K	340.00K
Revenue Actual	236.00K	1.65M	269.00K	404.00K

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar